ロード中...
Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients
BACKGROUND: No studies have been reported on the efficacy and safety of long-term (≥12 months) use of topical tacrolimus for refractory ocular surface inflammation in pediatric patients. METHODS: Medical records of pediatric patients who were prescribed topical 0.02% tacrolimus ointment for refracto...
保存先:
| 出版年: | BMC Ophthalmol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178927/ https://ncbi.nlm.nih.gov/pubmed/34088281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-021-01998-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|